YANG LAB - Key Persons

Job Titles:

• Endocrinologist

Endocrinologist Aaron Hsueh discovers obestatin, a hormone that supresses appetite and may lead to treatments for obesity.

Job Titles:

• Master Student, Mechanical Engineering

Job Titles:

• Student, University of Texas at Houston

Job Titles:

• Student in Bioengineering, Admitted Autumn 2022

Job Titles:

• Undergraduate, Vice Provost for Undergraduate Education

Job Titles:

• Pharmacologist

Pharmacologist Avram Goldstein discovers a chemical in the human brain that could lead to the development of powerful painkillers with fewer undesirable side effects.

Job Titles:

• Student, University of Texas at Houston

Job Titles:

• CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY

Job Titles:

• Student in Mechanical Engineering, Admitted Winter 2019

Job Titles:

• Current Position: CEO, CyteSi

Job Titles:

• Student, Illinois Institute of Technology

Job Titles:

• PRESIDENT & CEO / STANFORD HEALTH CARE

Job Titles:

• Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

Job Titles:

• Associate Professor of Ophthalmology and, by Courtesy, of Chemical Engineering
• Associate Professor of Ophthalmology at the Byers Eye Institute
• Director of the Stanford Teleophthalmology Autonomous Testing

Dr. Myung is an Associate Professor of Ophthalmology at the Byers Eye Institute at Stanford and, by courtesy, of Chemical Engineering. He is a board-certified ophthalmologist and attending physician specializing in cataract and corneal surgery and external diseases of the eye, and the Director of the Ophthalmic Innovation Program, a project-based fellowship in the development and regulatory science of new eye care technologies. Dr. Myung leads an NIH-funded translational research laboratory focused on two areas of clinical need: (1) ophthalmic regenerative medicine through tissue engineering and drug delivery, and (2) global health through mobile technologies and telemedicine. His research group takes an interdisciplinary approach toward fostering regeneration of ocular tissues, by using chemistry to not only build biomimetic cellular architectures but also to target and release bioactive molecules to promote healing. Current projects are directed toward the use of bio-orthogonal and supramolecular crosslinking chemistries for the localized delivery of growth factors and/or stem cells to wound sites, the synthesis of bioactive wound dressings and vehicles, the creation of biopolymeric tissue scaffolds, and 3D bioprintable inks for tissue engineering. Dr. Myung is also Director of the Stanford Teleophthalmology Autonomous Testing and Universal Screening (STATUS) Program, which is pushing the boundaries of telemedicine and AI to improve eye care worldwide. He and his collaborators investigate the role of mobile technologies and AI in enabling diagnostics and patient care outside of traditional health care settings. Their goal is to challenge current paradigms of eye care delivery through new digital health technologies and telemedicine to increase access to care in resource-limited settings both in the US and abroad. In collaboration with his retina, primary care, and endocrinologist colleagues at Stanford, he has organized and leads a Bay Area-wide Remote Diabetic Eye Care Program. Through this program, patients with diabetes can have their eyes photographed and analyzed by an FDA-cleared autonomous artificial intelligence algorithm at clinics throughout the Bay Area and then, if needed, referred in for further evaluation by a retina specialist. More information about the STATUS program can be found at: http://med.stanford.edu/ophthalmology/patient_care/tele-eyecare.html#remote_diabetic_eyecareprogram

Job Titles:

• Dean
• Physician
• Scientist
• Surgeon
• Carl and Elizabeth Naumann Dean of the School of Medicine
• CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
• Vice Dean Linda M. Boxer

Dean Minor is a leading physician, basic scientist and educator. Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University. As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, "Discovering Precision Health," describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond - a multi-decade journey enabled by Precision Health. In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University. Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms. In 2012, Dr. Minor was elected to the National Academy of Medicine. Carl and Elizabeth Naumann Dean of the School of Medicine, Vice President for Medical Affairs, Stanford University, Professor of Otolaryngology - Head and Neck Surgery, and Professor of Neurobiology and of Bioengineering, by courtesy Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor is also a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University. As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. He oversees the quality of Stanford Medicine's physicians on the faculty and in the organization's growing clinical networks and physician practices. In August 2023, Dr. Minor was appointed as Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University. Dr. Minor has demonstrated a steadfast commitment to diversity, equity, and inclusion. For example, between 2012 and 2022, the number of underrepresented students increased from 9.9 percent of incoming PhDs to 24.6 percent and from 14 percent of incoming MDs to 28.9 percent. Other key accomplishments include quadrupling the number of women department chairs and maintaining the highest NIH funding per faculty ratio in the country. With Dr. Minor's leadership, Stanford Medicine is leading the biomedical revolution through Precision Health. Empowering people to lead healthy lives, Precision Health is a fundamental shift to more proactive and personalized health care that predicts and prevents disease before it strikes - and cures it decisively if it does. His book, "Discovering Precision Health: Predict, Prevent, and Cure to Advance Health and Well-Being," highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. Dr. Minor also spearheaded the creation of an Integrated Strategic Plan (ISP) that reaffirms Stanford Medicine's Precision Health vision. A groundbreaking roadmap launched in 2018, the ISP aligns Stanford Medicine's three entities, informs how each will develop strategies, and has activated dozens of high-impact initiatives across Stanford Medicine. In 2023, Dr. Minor and the CEOs of Stanford Health Care and Stanford Medicine Children's Health launched the ISP Refresh, an initiative focused on Stanford Medicine's evolution as it leads a biomedical landscape that has rapidly evolved due to COVID-19 and other developments. At the beginning of the COVID-19 pandemic, Dr. Minor quickly implemented protocols to ensure the safety of patients and of the Stanford Medicine community. He emphasized open communication, transparency, and accountability as he and the leadership team responded to the unprecedented challenges that affected every facet of the enterprise's activities. Under his leadership, Stanford Medicine became one of the first academic medical centers to develop a COVID-19 test, launched hundreds of clinical research projects, and distributed 480,000 vaccine doses. In 2021, Dr. Minor articulated and began realizing a bold vision for transforming the future of life sciences at Stanford University, in the Bay Area, and beyond. This multi-decade journey will leverage the region's unique strengths in information sciences, technology, and biology and biomedicine to establish a biomedical innovation hub that, through collaboration, enhances fundamental understanding of biology and translates promising discoveries into transformative leaps that promote human and planetary well-being. Dr. Minor has long provided significant support for basic science research and for clinical and translational research at Stanford. Through bold initiatives in medical education and increased support for MD and PhD students, Dr. Minor is committed to inspiring and training future leaders. He also has increased student financial aid and expanded faculty leadership opportunities. Among other accomplishments, Dr. Minor has led the development and implementation of an innovative model for cancer research and patient care delivery at Stanford Medicine and has launched an initiative in biomedical data science to harness the power of big data and create a learning health care system. Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. As provost, Dr. Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation, and the Doctor of Philosophy Board to promote excellence in PhD education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care. Prior to his appointment as provost in 2009, Dr. Minor was the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in The Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training. With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière's disease, Dr. Minor received the Prosper Ménière Society's gold medal in 2010. In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998, Dr. Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms. Dr. Minor received his bachelor's and medical degrees from Brown University. He trained at Duke University Medical Center and the University of Chicago Medical Center and completed a research fellowship at the University of Chicago and a clinical fellowship at The Otology Group and The EAR Foundation in Nashville, Tennessee. In 2012, Dr. Minor was elected to the National Academy of Medicine. As part of the Stanford Executive Briefing series, Minor shares his thoughts on authentic leadership and offers five leadership principles.

Job Titles:

• Research Professor, Dankook University, South Korea

Job Titles:

• Research Interests

Job Titles:

• Researcher, National Seoul University, South Korea

Job Titles:

• Assistant Research Professor, Missouri University of Science and Technology

Job Titles:

• Post - Doctoral Fellow

Job Titles:

• Sleep Researcher

Sleep researcher Emmanuel Mignot identifies the defective gene that causes narcolepsy, a disabling sleep disorder affecting humans and animals.

Job Titles:

• Associate Professor of Materials Science and Engineering, Senior Fellow at the Woods Institute for the Environment and Associate Professor, by Courtesy, of Pediatrics ( Endocrinology )

Job Titles:

• Pathologist

Pathologist Eugene Butcher discovers a receptor that guides white blood cells into the peripheral lymph nodes.

Job Titles:

• Pathologist

Pathologist Gerald Crabtree develops techniques that allow scientists to toggle genes on and off in animal models.

Job Titles:

• Professor of Surgery ( Plastic and Reconstructive Surgery )

Job Titles:

• Student, University of Texas at Houston

Job Titles:

• Medical Institute Investigator

Job Titles:

• Immunologist

Immunologist Hugh McDevitt discovers regulatory genes believed to control the body's reponses to foreign proteins, which suggests that people may have predictable susceptibility to certain diseases.

Job Titles:

• Pathologist

Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems. Pathologist Irving Weissman identifies the stem cell that gives rise to bladder cancer, and also shows how the cell uses the "don't-eat-me" signal, a molecule known as CD47, to evade the body's defenses. Pathologist Irving Weissman shows that a single antibody, which counters the effect of the CD47 molecule, shrinks a variety of human tumors transplanted into mice.

Job Titles:

• Johnson and Johnson Professor of Surgery and Professor, by Courtesy, of Orthopaedic Surgery

Job Titles:

• Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease

John Farquhar and Peter Wood lead the first large clinical investigation that shows lowering cholesterol levels prevents heart disease.

Job Titles:

• Adjunct Clinical Professor, Surgery - Plastic & Reconstructive Surgery

Job Titles:

• Immunologist

Job Titles:

• Instructor, Molecular & Cellular Physiology

Job Titles:

• Instructor, Dermatology

Job Titles:

• Visiting Professor ( Nov 2011 - Dec 2012 ) Associate Professor of Lanzhou University, China

Job Titles:

• Student in Chemical Engineering, Admitted Autumn 2019

Job Titles:

• Support

Job Titles:

• Life Science Research Prof, SLAC National Accelerator Laboratory

Job Titles:

• Pathologist

Pathologist Marius Wernig turns mouse skin cells into cells that insulate neurons with the application of just three genes.

Job Titles:

• Immunologist

Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.

Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.

Job Titles:

• Executive Assistant to Dean Lloyd Minor, MD, Office of the Dean, Chief of Staff

Job Titles:

• Student, University of Texas at Houston

Job Titles:

• Postdoctoral Medical Fellow, Plastic and Reconstructive Surgery Resident in Surgery - Plastic & Reconstructive Surgery / 139 Total Publications

Job Titles:

• Student in Chemical Engineering, Admitted Autumn 2019

Job Titles:

• Associate Professor of Cardiothoracic Surgery ( Cardiothoracic Surgery Research ) and, by Courtesy, of Chemical Engineering

Dr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.

Job Titles:

• CEO
• PRESIDENT

Job Titles:

• Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease

Job Titles:

• Professor of Surgical Pathology

Job Titles:

• Basic Life Research Scientist, Rad / Pediatric Radiology

Job Titles:

• Researcher

Job Titles:

• Surgeon

Surgeon Roy Cohn leads the first human kidney transplant operation on the West Coast.

Job Titles:

• Adjunct Clinical Professor, Radiology

Job Titles:

• Radiologist

Radiologist Sanjiv Gambhir develops a new type of imaging system that can illuminate tumors in living subjects with a precision of nearly one-trillionth of a meter

Job Titles:

• Director, Geballe Laboratory for Advanced Materials ( GLAM ), Professor of Materials Science and Engineering and, by Courtesy, of Bioengineering and of Chemical Engineering

Job Titles:

• Medical Student, School of Medicine

Job Titles:

• Student, University of Texas at Houston

Job Titles:

• Senior Associate Dean, Graduate Education and Postdoctoral Affairs and Professor of Surgery ( Abdominal Transplantation ) Research

Job Titles:

• Undergraduate, Bioengineering Section Leader Coordinator, Digital Education

Job Titles:

• Postdoctoral Scholar, Materials Science and Engineering / 5 Total Publications

Job Titles:

• Scholar Project Advisor

Job Titles:

• Physician Scholars Research Grant, Stanford University School of Medicine ( 2014 )

Job Titles:

• Basic Life Res Scientist, Orthopaedic Surgery

Job Titles:

• Instructor, Institute for Stem Cell Biology and Regenerative Medicine / Research

Job Titles:

• Pediatrician

Pediatrician Thomas Robinson finds that children who curtailed their television time gained significantly less body fat than those who didn't .

Job Titles:

• Professor of Radiology ( Canary Cancer Center ) and, by Courtesy, of Electrical Engineering

Job Titles:

• Emeritus

Job Titles:

• Assistant Professor of Mechanical Engineering and, by Courtesy, of Materials Science and Engineering

Job Titles:

• Undergraduate, Vice Provost for Undergraduate Education

Job Titles:

• Researcher

Researcher William Haskell shows that intensive lifestyle changes and prevention/treatment programs can reduce cardiac events and slow the progression of atherosclerosis in coronary arteries.

Job Titles:

• Researcher

Researcher William S. Robinson isolates the genetic blueprint of a virus that causes hepatitis B and a common form of liver cancer.

Job Titles:

• Current Position: Professor at Chong Qing Medical College